Physician
University Otolaryngologists INC
University Otolaryngologists INC was paid $3.73M by Medicaid between Jan 2018 and Dec 2024, across 30 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 32% of everything it billed.
33Billing provider infoUNIVERSITY OTOLARYNGOLOGISTS INC
DUBLIN, OH 43016
DUBLIN, OH 43016
33aNPI1750330551assigned 05/09/2006
33bProvider typeNeuro-ophthalmology Physician
28Total paid$3.73M
24GClaims99,967
24DCodes billed30
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,684 | $359K | |
| 2019 | 10,754 | $393K | |
| 2020 | 9,451 | $290K | |
| 2021 | 13,872 | $552K | |
| 2022 | 17,882 | $702K | |
| 2023 | 20,770 | $773K | |
| 2024incomplete | 16,554 | $663K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 32% | 8,155 | 7,778 | $1.18M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 18,275 | 16,936 | $621K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 7,112 | 6,658 | $384K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.6% | 5,102 | 4,771 | $360K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.0% | 6,627 | 6,157 | $298K |
| 95117 | 4.0% | 17,745 | 9,383 | $148K | |
| 31231 | 2.8% | 1,382 | 1,273 | $105K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 2.5% | 1,782 | 1,680 | $95K |
| 95115 | 2.4% | 13,273 | 7,726 | $89K | |
| 99243 | 2.0% | 1,529 | 1,472 | $76K | |
| 95024 | 2.0% | 2,864 | 2,742 | $75K | |
| 92557 | 1.6% | 2,620 | 2,411 | $61K |
18 more codes
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.5% | 719 | $55K |
| 92567 | 1.2% | 4,299 | $43K | |
| 94375 | <1% | 1,635 | $35K | |
| 92083 | <1% | 1,491 | $32K | |
| 92133 | <1% | 1,741 | $22K | |
| 31575 | <1% | 314 | $16K | |
| 95012 | <1% | 1,042 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 455 | $10K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 108 | $6K |
| 95811 | <1% | 74 | $5K | |
| 92060 | <1% | 163 | $2K | |
| 92504 | <1% | 174 | $2K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 15 | $2K |
| 99253 | <1% | 31 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $1K |
| 69210 | <1% | 30 | $463.49 | |
| 99072 | <1% | 1,160 | $30.60 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEZOLD, HOLLY (CEO)